Cargando…
Micro-Raman spectroscopy study of blood samples from myocardial infarction patients
Acute myocardial infarction (MI) is found to be a major causative factor for global mortality and morbidity. This situation demands necessity of developing efficient and rapid diagnostic tools to detect acute MI. Raman spectroscopy is a non-destructive optical diagnostic technique, which has high po...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer London
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9708773/ https://www.ncbi.nlm.nih.gov/pubmed/35821543 http://dx.doi.org/10.1007/s10103-022-03604-1 |
_version_ | 1784841012170981376 |
---|---|
author | John, Reena V. Devasia, Tom N., Mithun Lukose, Jijo Chidangil, Santhosh |
author_facet | John, Reena V. Devasia, Tom N., Mithun Lukose, Jijo Chidangil, Santhosh |
author_sort | John, Reena V. |
collection | PubMed |
description | Acute myocardial infarction (MI) is found to be a major causative factor for global mortality and morbidity. This situation demands necessity of developing efficient and rapid diagnostic tools to detect acute MI. Raman spectroscopy is a non-destructive optical diagnostic technique, which has high potential in probing biochemical changes in clinical samples during initiation and progress of diseases. In this work, blood was taken as the sample to examine inflammation in acute MI patients using Raman spectroscopy. Ratio of Raman peak intensities that corresponds to phenylalanine (1000 cm(−1)) and tyrosine (825 cm(−1)) can facilitate indirect information about tetrahydrobiopterin (BH4) availability, which can indicate inflammatory status in patients. This ratio obtained was higher for MI patients in comparison with control subjects. The decrease in phenylalanine and tyrosine ratio (Phe-Tyr ratio) is attributed to the prognosis of standard of care (medications like antiplatelets including aspirin, statin and revascularisation) leading to inflammation reduction. Phe-Tyr ratio estimated from the Raman spectra of blood can be exploited as a reliable method to probe inflammation due to MI. The method is highly objective, require only microliters of sample and minimal sample preparation, signifying its clinical utility. |
format | Online Article Text |
id | pubmed-9708773 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Springer London |
record_format | MEDLINE/PubMed |
spelling | pubmed-97087732022-12-01 Micro-Raman spectroscopy study of blood samples from myocardial infarction patients John, Reena V. Devasia, Tom N., Mithun Lukose, Jijo Chidangil, Santhosh Lasers Med Sci Original Article Acute myocardial infarction (MI) is found to be a major causative factor for global mortality and morbidity. This situation demands necessity of developing efficient and rapid diagnostic tools to detect acute MI. Raman spectroscopy is a non-destructive optical diagnostic technique, which has high potential in probing biochemical changes in clinical samples during initiation and progress of diseases. In this work, blood was taken as the sample to examine inflammation in acute MI patients using Raman spectroscopy. Ratio of Raman peak intensities that corresponds to phenylalanine (1000 cm(−1)) and tyrosine (825 cm(−1)) can facilitate indirect information about tetrahydrobiopterin (BH4) availability, which can indicate inflammatory status in patients. This ratio obtained was higher for MI patients in comparison with control subjects. The decrease in phenylalanine and tyrosine ratio (Phe-Tyr ratio) is attributed to the prognosis of standard of care (medications like antiplatelets including aspirin, statin and revascularisation) leading to inflammation reduction. Phe-Tyr ratio estimated from the Raman spectra of blood can be exploited as a reliable method to probe inflammation due to MI. The method is highly objective, require only microliters of sample and minimal sample preparation, signifying its clinical utility. Springer London 2022-07-12 2022 /pmc/articles/PMC9708773/ /pubmed/35821543 http://dx.doi.org/10.1007/s10103-022-03604-1 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Original Article John, Reena V. Devasia, Tom N., Mithun Lukose, Jijo Chidangil, Santhosh Micro-Raman spectroscopy study of blood samples from myocardial infarction patients |
title | Micro-Raman spectroscopy study of blood samples from myocardial infarction patients |
title_full | Micro-Raman spectroscopy study of blood samples from myocardial infarction patients |
title_fullStr | Micro-Raman spectroscopy study of blood samples from myocardial infarction patients |
title_full_unstemmed | Micro-Raman spectroscopy study of blood samples from myocardial infarction patients |
title_short | Micro-Raman spectroscopy study of blood samples from myocardial infarction patients |
title_sort | micro-raman spectroscopy study of blood samples from myocardial infarction patients |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9708773/ https://www.ncbi.nlm.nih.gov/pubmed/35821543 http://dx.doi.org/10.1007/s10103-022-03604-1 |
work_keys_str_mv | AT johnreenav microramanspectroscopystudyofbloodsamplesfrommyocardialinfarctionpatients AT devasiatom microramanspectroscopystudyofbloodsamplesfrommyocardialinfarctionpatients AT nmithun microramanspectroscopystudyofbloodsamplesfrommyocardialinfarctionpatients AT lukosejijo microramanspectroscopystudyofbloodsamplesfrommyocardialinfarctionpatients AT chidangilsanthosh microramanspectroscopystudyofbloodsamplesfrommyocardialinfarctionpatients |